Chretien et al. (78) were able to show that AML patients with a particular mutation (inversion 3) developed a CD16+ CD56- unconventional NK subpopulation, representing more than 20% of the total NK cells. The gene discussed is NCAM1; the disease is acute myeloid leukemia.